Anterogen Co Ltd (065660) Stock Price & News

Why is 065660 up 2.71%?

Dive Deeper

065660:KOSDAQ

Anterogen Co Ltd

₩14,400.00

+2.71%

(+380.00) 1D

Oct 16, 3:30:11 PM GMT+9 · KRW

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 065660...

Open

₩14,020

High

₩14,720

Low

₩13,390

Mkt. cap

144.09B

Avg. vol.

18.91K

Volume

33.53K

52-wk high

₩61,800

52-wk low

₩13,390

EPS

-₩161

Shares outstanding

10.01M

No. of employees

Open

₩14,020

High

₩14,720

Low

₩13,390

Mkt. cap

144.09B

Avg. vol.

18.91K

Volume

33.53K

52-wk high

₩61,800

52-wk low

₩13,390

EPS

-₩161

Shares outstanding

10.01M

No. of employees

Related stocks

004310

Hyundai Pharmaceutical Co Ltd

Hyundai BioLand Co Ltd

News stories

From web sources and news partners

bloomingbit

32 minutes ago

[Analysis] Bitcoin Seen Unlikely to Fall to $10,000 Even if S&P 500 Corrects 20%

AOL.com

1 hour ago

Wall Street's record breakouts unravel as investors dump recent winners: Chart of the Day

Yahoo Finance

3 hours ago

Missing the S&P 500's 10 Best Days in 20 Years Cut a $10,000 Investment's Ending Value by More Than Half

TradingKey

9 hours ago

US Stock Bull Market Enters Fifth Year: Can S&P 500 Withstand Rising Treasury Yield Pressures After Doubling?

About Anterogen Co Ltd

CEOKim Mi-hyun | Lee Sung-goo

Employees36

Founded2000

Headquarters-

SectorBiotechnology

Websiteanterogen.com

All values in KRW	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	2.04B	2.00B	2.12B	2.20B
Cost of goods sold	1.31B	1.30B	1.41B	1.50B
Cost of revenue	1.31B	1.30B	1.41B	1.50B
Research and development expenses	599.22M	716.29M	1.30B	710.38M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	415.91M	387.62M	435.42M	388.03M
Operating expense	1.14B	1.18B	1.81B	1.18B
Total operating expenses	2.45B	2.48B	3.22B	2.68B
Operating income	-405.69M	-474.86M	-1.10B	-477.81M
Other non operating income	1.41M	-4.87M	1.35M	698.65K
EBT including unusual items	-79.32M	-226.10M	-882.26M	-149.87M
EBT excluding unusual items	-79.29M	-228.38M	-880.03M	-152.18M
Income tax expense	-	279.54M	-	-
Effective tax rate	-	-123.63%	-	-
Other operating expenses	45.94M	13.52M	9.45M	6.53M
Net income	-79.32M	-505.64M	-882.26M	-149.87M
Net profit margin	-3.88%	-25.24%	-41.55%	-6.81%
Earnings per share	-	-	-	-
Interest and investment income	339.23M	310.47M	222.80M	367.19M
Interest expense	-	-	-	-
Net interest expenses	339.23M	310.47M	222.80M	367.19M
Depreciation and amortization charges	56.37M	56.65M	56.64M	52.20M
EBITDA	-258.52M	-324.52M	-956.12M	-337.29M
Gain or loss from assets sale	30.50K	-	17.08K	-

Ask anything